Surgery and chemotherapy cannot improve the survival of patients with early-stage mucosa-associated lymphoid tissue derived primary pulmonary lymphoma

Surgery and chemotherapy cannot improve the survival of patients with early-stage mucosa-associated lymphoid tissue derived primary pulmonary lymphoma

BackgroundTo date, there is no treatment consensus on mucosa-associated lymphoid tissue (MALT) derived primary pulmonary lymphoma (PPL).MethodsWe identified patients with early-stage MALT-type PPL from the National Cancer Institute’s Surveillance, Epidemiology, and End Results program database. The...

Full description

Bibliographic Details
Main Authors: Huahang Lin, Ke Zhou, Zhiyu Peng, Linchuan Liang, Jie Cao, Jiandong Mei
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Oncology
Subjects:
early-stage
mucosa-associated lymphoid tissue
primary pulmonary lymphoma
propensity score-matching analysis
survival
treatment modalities
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.965727/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.965727/full

Similar Items